Functional
Molecules from
|
|
Organised by RSC Biotechnology Group
Naturally-occurring compounds have been, and continue to be, an
important source of new leads and commercially successful products for
various industrial sectors, notably pharmaceuticals and agrochemicals.
The last decade has, however, seen many challenges as well as new
opportunities for the industrial utilization of molecules from natural
sources, including the birth of 'nutraceuticals' and 'cosmeceuticals'.
This conference follows two earlier successful meetings organised by the
Biotechnology Group at the University of Sussex in 1996 and at the
University of St Andrews in 1999 and aims to highlight current trends,
challenges and successes in the exploitation of natural products.
Programme includes:
Dwight Baker (Cubist, USA)
Sir Jack Baldwin (Oxford, UK)
Gerhard Bringmann (Würzburg, Germany)
Tony Buss (Merlion Pharmaceuticals, Singapore)
John Casey (Unilever R&D, Colworth Science Park,UK)
Guy Carter (Wyeth, USA)
John Clough (Syngenta, UK)
Mike Dawson (Novacta Therapeutics, UK)
Peter Leadlay (Cambridge, UK)
Andrew Mearns Spragg (Aquapharm Bio-Discovery, UK)
Jason Micklefield (Manchester, UK)
Jacob Midiwo (Nairobi, Kenya)
Robert Nash (Summit Wales Ltd, UK)
David Newman (National Institure of Cancer Research, USA)
Neville Nicholson (GlaxoSmithKline, UK)
John Pickett (Rothamsted Research, UK)
Jürgen Rohr (Kentucky, USA)
Tom Simpson (Bristol, UK)
Sheo Singh (Merck, USA)
Andrew Takle (GlaxoSmithKline, UK)
Call for Papers
Participants who would like to present their work as a poster
are invited to submit an abstract by
31 March. Please send a one-page abstract in Microsoft Word as
an e-mail attachment to
esw@confsec.co.uk Some of these will be selected by the
organising committee for short oral presentations.
Further information
Full details of the venue, travel, accommodation options, student bursaries, social events and fees can be found in the final circular.
Please click here to
open the circular in pdf format.